Middle East
Abu Dhabi rolls out whole-genome sequencing for newborns
Abu Dhabi rolls out whole-genome sequencing for newborns
The programme screens over 815 treatable childhood genetic conditions.
3 days ago
Acıbadem Healthcare acquires 80% stake in Bayındır Group
Facilities under the group will operate under the “Acıbadem-Bayındır” brand.
5 days ago
Saudi, Iraq sign MoU to develop sustainable healthcare partnerships
The meeting focused on expanding bilateral cooperation.
Burjeel Holdings' net profit surges 129% to $40.3m in Q2
Revenue grew 18.7% to $382m (AED 1.4b).
Jordan breaks ground on first PPP government hospital in Madaba
The facility will be built by KBW Investments.
Burjeel Hospital opens interventional pain management centre in Dubai
Key services include spinal cord and DRS stimulation.
Abu Dhabi’s value-based initiative incentivises care quality
The programme will initially focus on fertility services.
Abu Dhabi unveils regional vaccine distribution hub
The facility will manage a portfolio of over 20 vaccines.
Fakeeh Health opens smart clinic in Dubai Airport Free Zone
The facility uses AI tools to record vital signs.
Abu Dhabi launches new integrated postnatal care initiative
The programme combines home visits, telemedicine, and outpatient services.
Abu Dhabi, US hospital partner on paediatric cell and gene therapies
Both will offer specialised fellowships, joint training programmes, and workshops.
Abu Dhabi fast-tracks access to new IBD medication
It is the first outside the US to offer the treatment.
Abu Dhabi to develop genome surgery centres in new partnership
CRISPR-based technologies will be used for customised treatments.
Burjeel acquires PhysioTrio in Riyadh, Saudi Arabia
The centre will become a part of the group’s PhysioTherabia network.
Sheikh Shakhbout Medical City launches clinic for int’l travellers
The facility offers personalised consultations and health guidance.
Burjeel Holdings acquires Dubai’s Medeor 24x7 Hospital building for $46.3m
The facility previously had a lease commitment of $93.4m (AED 343m) over 15 years.
Abu Dhabi and Abbott partner to localise pharmaceutical manufacturing
One key area is the development of biosimilars.